Loading data for SANA — first visit, this takes a few seconds.

Alerta

Sana Biotechnology Inc. (SANA)

NasdaqGS: SANA · Precio en tiempo real · USD

3.91

+0.17 (4.55%)

Al cierre: Aug 21, 2026, 8:00 PM

3.90

-0.26%

Fuera de horario: 7:54 PM

El precio, las cifras principales y las últimas noticias, en un solo sitio.

4.55% (1D)

No hay datos disponibles

Precio de compra	2.92
Capitalización de mercado	1.17B
Ingresos (TTM)	n/a
Beneficio neto (TTM)	-211.82M
	2.10
	-0.75
	n/a
	-7.04
P/B (TTM)	8.85
P/S (TTM)	n/a
Fecha de resultados	Nov 5, 2026

Precio de venta	4.83
Volumen	2,897,033
Volumen medio (20D)	3,280,719
Abierto	3.79
Anterior Cerrar	3.74
Rango del día	3.74 - 4.10
Rango de 52 semanas	2.61 - 6.55
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de SANA

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical t...

[Leer más]

Industria Biotechnology

Sector Healthcare

IPO Fecha Feb 4, 2021

Empleados 142

Bolsa de Valores NasdaqGS

Símbolo bursátil SANA

Sitio web https://www.sana.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Sana Biotechnology fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -244.17M, una disminución de -8.47%.

Estados financieros

Sorpresa de resultados

Sana Biotechnology ha publicado sus resultados trimestrales en Aug 10, 2026:

Ingresos de $0 falla las estimaciones por $0, con NaN% Crecimiento interanual.
EPS de -0.13 falla las estimaciones por -0.01, con 18.75% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que Sana Biotechnology Inc. publique sus resultados el Nov 5, 2026, durante el horario de mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

1 mes hace · Zacks

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

1 mes hace · Simply Wall St.

Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM

Sana Biotechnology (NasdaqGS:SANA) reported long term follow up data from an investigator sponsored study of its HIP modified islet cell therapy for type 1 diabetes. Results published in The New Engla...

1 mes hace · Zacks

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana (SANA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 meses hace · Euronews

‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.View on eu...

4 meses hace · Insider Monkey

Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes

Sana Biotechnology (NASDAQ:SANA) is one of the small cap stocks with the highest upside potential. On April 13, Sana Biotechnology and Mayo Clinic entered into a collaboration to accelerate the develo...

Página 1 de 2

Sana Biotechnology Inc. (SANA)